AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus

Japanese encephalitis virus (JEV) is an enveloped icosahedral capsid virus with a prime neutralizing epitope present in E protein domain III (EDIII). E dimers are rearranged into a five-fold symmetry of icosahedrons. Cholera toxin B (CTB) and heat-labile enterotoxin B (LTB) of AB<sub>5</sub...

Full description

Bibliographic Details
Main Authors: Jina Ahn, Ji Eun Yu, Hanna Kim, Jemin Sung, Gyoonhee Han, Myung Hyun Sohn, Baik-Lin Seong
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/15/7/425
_version_ 1797587349483290624
author Jina Ahn
Ji Eun Yu
Hanna Kim
Jemin Sung
Gyoonhee Han
Myung Hyun Sohn
Baik-Lin Seong
author_facet Jina Ahn
Ji Eun Yu
Hanna Kim
Jemin Sung
Gyoonhee Han
Myung Hyun Sohn
Baik-Lin Seong
author_sort Jina Ahn
collection DOAJ
description Japanese encephalitis virus (JEV) is an enveloped icosahedral capsid virus with a prime neutralizing epitope present in E protein domain III (EDIII). E dimers are rearranged into a five-fold symmetry of icosahedrons. Cholera toxin B (CTB) and heat-labile enterotoxin B (LTB) of AB<sub>5</sub>-type toxin was used as the structural scaffold for emulating the pentameric axis of EDIII. We produced homo-pentameric EDIII through the genetic fusion of LTB or CTB in <i>E. coli</i> without recourse to additional refolding steps. Harnessing an RNA-mediated chaperone further enhanced the soluble expression and pentameric assembly of the chimeric antigen. The pentameric assembly was validated by size exclusion chromatography (SEC), non-reduced gel analysis, and a GM1 binding assay. CTB/LTB−EDIII chimeric antigen triggered high neutralizing antibodies against the JEV Nakayama strain after immunization in mice. Altogether, our proof-of-principle study creating a JEV-protective antigen via fusion with an AB<sub>5</sub>-type toxin as both a pentameric scaffold and a built-in adjuvant posits the bacterially produced recombinant chimeric antigen as a cost-effective alternative to conventional inactivated vaccines against JEV.
first_indexed 2024-03-11T00:35:19Z
format Article
id doaj.art-83458f20a44245b4b01d356cad491e4f
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-03-11T00:35:19Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-83458f20a44245b4b01d356cad491e4f2023-11-18T21:38:00ZengMDPI AGToxins2072-66512023-06-0115742510.3390/toxins15070425AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis VirusJina Ahn0Ji Eun Yu1Hanna Kim2Jemin Sung3Gyoonhee Han4Myung Hyun Sohn5Baik-Lin Seong6The Interdisciplinary Graduate Program in Integrative Biotechnology & Translational Medicine, Yonsei University, Incheon 21983, Republic of KoreaDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of KoreaDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of KoreaDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of KoreaDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03708, Republic of KoreaDepartment of Pediatrics, College of Medicine, Yonsei University, Seoul 03722, Republic of KoreaDepartment of Microbiology, College of Medicine, Yonsei University, Seoul 03722, Republic of KoreaJapanese encephalitis virus (JEV) is an enveloped icosahedral capsid virus with a prime neutralizing epitope present in E protein domain III (EDIII). E dimers are rearranged into a five-fold symmetry of icosahedrons. Cholera toxin B (CTB) and heat-labile enterotoxin B (LTB) of AB<sub>5</sub>-type toxin was used as the structural scaffold for emulating the pentameric axis of EDIII. We produced homo-pentameric EDIII through the genetic fusion of LTB or CTB in <i>E. coli</i> without recourse to additional refolding steps. Harnessing an RNA-mediated chaperone further enhanced the soluble expression and pentameric assembly of the chimeric antigen. The pentameric assembly was validated by size exclusion chromatography (SEC), non-reduced gel analysis, and a GM1 binding assay. CTB/LTB−EDIII chimeric antigen triggered high neutralizing antibodies against the JEV Nakayama strain after immunization in mice. Altogether, our proof-of-principle study creating a JEV-protective antigen via fusion with an AB<sub>5</sub>-type toxin as both a pentameric scaffold and a built-in adjuvant posits the bacterially produced recombinant chimeric antigen as a cost-effective alternative to conventional inactivated vaccines against JEV.https://www.mdpi.com/2072-6651/15/7/425chapernaJapanese encephalitis virusprotein foldingrecombinant vaccine
spellingShingle Jina Ahn
Ji Eun Yu
Hanna Kim
Jemin Sung
Gyoonhee Han
Myung Hyun Sohn
Baik-Lin Seong
AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
Toxins
chaperna
Japanese encephalitis virus
protein folding
recombinant vaccine
title AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
title_full AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
title_fullStr AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
title_full_unstemmed AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
title_short AB<sub>5</sub>-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
title_sort ab sub 5 sub type toxin as a pentameric scaffold in recombinant vaccines against the japanese encephalitis virus
topic chaperna
Japanese encephalitis virus
protein folding
recombinant vaccine
url https://www.mdpi.com/2072-6651/15/7/425
work_keys_str_mv AT jinaahn absub5subtypetoxinasapentamericscaffoldinrecombinantvaccinesagainstthejapaneseencephalitisvirus
AT jieunyu absub5subtypetoxinasapentamericscaffoldinrecombinantvaccinesagainstthejapaneseencephalitisvirus
AT hannakim absub5subtypetoxinasapentamericscaffoldinrecombinantvaccinesagainstthejapaneseencephalitisvirus
AT jeminsung absub5subtypetoxinasapentamericscaffoldinrecombinantvaccinesagainstthejapaneseencephalitisvirus
AT gyoonheehan absub5subtypetoxinasapentamericscaffoldinrecombinantvaccinesagainstthejapaneseencephalitisvirus
AT myunghyunsohn absub5subtypetoxinasapentamericscaffoldinrecombinantvaccinesagainstthejapaneseencephalitisvirus
AT baiklinseong absub5subtypetoxinasapentamericscaffoldinrecombinantvaccinesagainstthejapaneseencephalitisvirus